Scientists at Northwestern University, Chicago have transformed stem cells into a key type of brain cell that dies early in Alzheimer's disease. Their findings will allow scientists to study what causes the cells to die in Alzheimer's, potentially paving the way for new treatments.
The researchers created a specific type of nerve cells, called basal forebrain cholinergic neurons. These cells, present in small numbers in the brain, are involved in retrieving memories and are lost early in the neurodegenerative disease.
The researchers created the nerve cells using embryonic stem cells. The nerve cells could be used to test new treatments in the lab and, one day, be used to develop stem cell therapy, by transplanting the cells into people with the disease.
Dr Christopher Bissonnette, who led the research at Northwestern University, said: 'The technique to produce these neurons allows for an almost infinite number of these cells to be grown in labs, allowing other scientists the ability to study why this one population of cells selectively dies in Alzheimer's disease'.
Dr Christopher Bissonnette, who led the research at Northwestern University, said: 'The technique to produce these neurons allows for an almost infinite number of these cells to be grown in labs, allowing other scientists the ability to study why this one population of cells selectively dies in Alzheimer's disease'.
Dr Simon Ridley, head of research at Alzheimer's Research UK, said: 'We're a very long way off transplanting stem cells as a treatment for Alzheimer's, but this development could boost progress towards treatments by making the disease easier to study in the lab'.
'Stem cell research has the potential to increase our understanding about what happens in the brain when Alzheimer's takes hold. If we can understand what causes the brain cells to die we will have a better chance of finding ways to prevent cell death and fight the disease. However, the science behind stem cell therapy is still at an early stage and there is no evidence yet to suggest this method will be able to help people with dementia'.
The research was published in the journal Stem Cells.
Related Articles
Alzheimer's memory loss due to gene blockade reversed in mice
An enzyme associated with memory loss can be blocked to reverse symptoms of Alzheimer's disease in mice, a study has shown...
Alzheimer's brain cells grown from skin cells of Down's syndrome patients
Skin cells from volunteers with Down's syndrome have been turned into brain cells in order to provide a new model for researchers to study Alzheimer's disease...
Two RNA studies give clues to neurodegeneration
Two independent studies have suggested new targets for treating neurodegenerative diseases...
CIRM gives $243m more funding to stem cell research
The California Institute for Regenerative Medicine (CIRM) in San Francisco has approved a further $243 million to encourage researchers working on stem cell therapies to push forward into the clinical trial phase...
Alzheimer's gene variant impairs the middle-aged, scientists say
Middle-aged people without Alzheimer's disease who have a 'high risk' variant of the TOMM40 gene are more likely to have poorer memory, new research findings suggest...
Genetic variants linked to early-onset dementia
An international team of scientists have identified two genetic variants associated with fronto-temporal dementia (FTD), a common form of early onset dementia. The study, published in Nature Genetics, could help in the search for new treatments to tackle the disease....
Scientists announce 'huge step forward' in stem cell research
A research team at Stanford University School of Medicine has for the first time successfully transformed mouse skin cells directly into neurons. They achieved this by infecting the skin cells with a genetically modified virus that inserts three different genes into the cells' DNA...
Three new gene variants linked to late-onset Alzheimer's disease
British and French researchers this week announced the discovery of three new genes linked to late-onset Alzheimer's disease, certain variations in which may increase a person's risk of developing the disease by 10-15 per cent. If new drugs could be developed to counter the effects of these mutations, it could help to prevent 20 per cent, the equivalent of 100,000 cases, of Alzheimer's disease in the UK per year, the researchers claim....
Most aren’t worried by Alzheimer’s gene risk test results, study shows
Findings published last week suggest that people are not troubled upon learning they are at higher risk of developing Alzheimer’s disease. Writing in the New England Journal of Medicine, researchers at the Boston University School of Medicine, US, led by Dr Robert Green, measured participants’ anxiety levels following results of a genetic test. The paper arrives amidst debate on how harmful direct-to-customer genetics testing - offered by companies such as 23andMe and DeCodeMe - might actuall...
Genome-wide study links four new genes to Alzheimer's
A study examining the genomes of more than 1,300 families has revealed four new genes potentially linked to the most common late-onset form of Alzheimer's disease, according to a study published in the American Journal of Human Genetics last week. The researchers, based at the Massachusetts General...
Leave a Reply
You must be logged in to post a comment.